European Association of Nuclear Medicine: Prostate cancer patients who are resistant to hormone treatment used to have a poor prognosis. Until recently, the diagnostic and therapeutic possibilities had been limited, but now innovative developments in nuclear medicine imaging and therapy open up promising pathways. Novel substances used with PET/CT (positron-emission tomography combined with computed tomography) not only allow for better diagnosis but also offer treatment options where other therapies have failed.
Latest from John Shanahan
- Activos energetico y desarrollo (Edggar Ocampo Tellez) Mexicon Spanish
- Kim regime weaponizes electricity (Robert Bryce) USofA North Korea
- Rethinking extinction (Stewart Brand) USofA
- The Netherlands carbon dilemma sequester or recycle (Alexander Hellemans)
- Inconvenient truths about recycling (Investor's Business Daily) USofA